I design small molecules and natural product–inspired scaffolds, coupling 2D/3D cell culture with phenotypic assays (viability, migration, cell cycle) and mechanism studies to modulate oncogenic signaling. Leads advance via ADMET profiling toward solid‑tumor therapeutics.